Literature DB >> 10521294

Association of hereditary nonpolyposis colorectal cancer-related tumors displaying low microsatellite instability with MSH6 germline mutations.

Y Wu1, M J Berends, R G Mensink, C Kempinga, R H Sijmons, A G van Der Zee, H Hollema, J H Kleibeuker, C H Buys, R M Hofstra.   

Abstract

Hereditary nonpolyposis colorectal cancer (HNPCC) (Amsterdam criteria) is often caused by mutations in mismatch repair (MMR) genes, and tumors of patients with HNPCC show microsatellite instability (MSI-high phenotype). Germline mutations of MMR genes have rarely been found in families that have HNPCC or suspected HNPCC and that do not show microsatellite instability (MSI-low phenotype). Therefore, an MSI-high phenotype is often used as an inclusion criterion for mutation testing of MMR genes. Correction of base-base mismatches is the major function of MSH6. Since mismatches present with an MSI-low phenotype, we assumed that the phenotype in patients with HNPCC-related tumors might be associated with MSH6 germline mutations. We divided 36 patients with suspected HNPCC into an MSI-low group (n=18) and an MSI-high group (n=18), on the basis of the results of MSI testing. Additionally, three unrelated patients from Amsterdam families with MSI-low tumors were investigated. All patients were screened for MSH2, MLH1, and MSH6 mutations. Four presumably causative MSH6 mutations were detected in the patients (22%) who had suspected HNPCC and MSI-low tumors. Furthermore, we detected one frameshift mutation in one of the three patients with HNPCC and MSI-low tumors. In the MSI-high group, one MSH6 missense mutation was found, but the same patient also had an MLH1 mutation, which may explain the MSI-high phenotype. These results suggest that MSH6 may be involved in a substantial proportion of patients with HNPCC or suspected HNPCC and MSI-low tumors. Our data emphasize that an MSI-low phenotype cannot be considered an exclusion criterion for mutation testing of MMR genes in general.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10521294      PMCID: PMC1288281          DOI: 10.1086/302612

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  26 in total

1.  Genetic variation at five trimeric and tetrameric tandem repeat loci in four human population groups.

Authors:  A Edwards; H A Hammond; L Jin; C T Caskey; R Chakraborty
Journal:  Genomics       Date:  1992-02       Impact factor: 5.736

Review 2.  Mutations predisposing to hereditary nonpolyposis colorectal cancer.

Authors:  P Peltomäki; A de la Chapelle
Journal:  Adv Cancer Res       Date:  1997       Impact factor: 6.242

3.  Purification of DNA from formaldehyde fixed and paraffin embedded human tissue.

Authors:  S E Goelz; S R Hamilton; B Vogelstein
Journal:  Biochem Biophys Res Commun       Date:  1985-07-16       Impact factor: 3.575

4.  Presence and instability of repetitive elements in sequences the altered expression of which characterizes risk for colonic cancer.

Authors:  J Chen; B G Heerdt; L H Augenlicht
Journal:  Cancer Res       Date:  1995-01-01       Impact factor: 12.701

5.  Clues to the pathogenesis of familial colorectal cancer.

Authors:  L A Aaltonen; P Peltomäki; F S Leach; P Sistonen; L Pylkkänen; J P Mecklin; H Järvinen; S M Powell; J Jen; S R Hamilton
Journal:  Science       Date:  1993-05-07       Impact factor: 47.728

6.  Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability.

Authors:  S Markowitz; J Wang; L Myeroff; R Parsons; L Sun; J Lutterbaugh; R S Fan; E Zborowska; K W Kinzler; B Vogelstein
Journal:  Science       Date:  1995-06-02       Impact factor: 47.728

7.  Microsatellite instability is associated with tumors that characterize the hereditary non-polyposis colorectal carcinoma syndrome.

Authors:  P Peltomäki; R A Lothe; L A Aaltonen; L Pylkkänen; M Nyström-Lahti; R Seruca; L David; R Holm; D Ryberg; A Haugen
Journal:  Cancer Res       Date:  1993-12-15       Impact factor: 12.701

8.  Isolation of an hMSH2-p160 heterodimer that restores DNA mismatch repair to tumor cells.

Authors:  J T Drummond; G M Li; M J Longley; P Modrich
Journal:  Science       Date:  1995-06-30       Impact factor: 47.728

9.  GTBP, a 160-kilodalton protein essential for mismatch-binding activity in human cells.

Authors:  F Palombo; P Gallinari; I Iaccarino; T Lettieri; M Hughes; A D'Arrigo; O Truong; J J Hsuan; J Jiricny
Journal:  Science       Date:  1995-06-30       Impact factor: 47.728

10.  Mutations of GTBP in genetically unstable cells.

Authors:  N Papadopoulos; N C Nicolaides; B Liu; R Parsons; C Lengauer; F Palombo; A D'Arrigo; S Markowitz; J K Willson; K W Kinzler
Journal:  Science       Date:  1995-06-30       Impact factor: 47.728

View more
  95 in total

1.  Regulation of the human MSH6 gene by the Sp1 transcription factor and alteration of promoter activity and expression by polymorphisms.

Authors:  Isabella Gazzoli; Richard D Kolodner
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

2.  Measurement of DNA mismatch repair activity in live cells.

Authors:  Xiufen Lei; Yong Zhu; Alan Tomkinson; LuZhe Sun
Journal:  Nucleic Acids Res       Date:  2004-07-12       Impact factor: 16.971

3.  Should we remove all lesions at colonoscopy?

Authors:  B Rembacken
Journal:  Gut       Date:  2004-12       Impact factor: 23.059

4.  Bethesda criteria for microsatellite instability testing: impact on the detection of new cases of Lynch syndrome.

Authors:  Miguel Serrano; Pedro Lage; Sara Belga; Bruno Filipe; Inês Francisco; Paula Rodrigues; Ricardo Fonseca; Paula Chaves; Isabel Claro; Cristina Albuquerque; António Dias Pereira
Journal:  Fam Cancer       Date:  2012-12       Impact factor: 2.375

5.  Epigenetic and copy number variation analysis in retinoblastoma by MS-MLPA.

Authors:  Gabriella Livide; Maria Carmela Epistolato; Mariangela Amenduni; Vittoria Disciglio; Annabella Marozza; Maria Antonietta Mencarelli; Paolo Toti; Stefano Lazzi; Theodora Hadjistilianou; Sonia De Francesco; Alfonso D'Ambrosio; Alessandra Renieri; Francesca Ariani
Journal:  Pathol Oncol Res       Date:  2012-01-26       Impact factor: 3.201

6.  Assessing the predictive accuracy of hMLH1 and hMSH2 mutation probability models.

Authors:  Kory W Jasperson; Katrina Lowstuter; Jeffrey N Weitzel
Journal:  J Genet Couns       Date:  2006-10       Impact factor: 2.537

7.  Hereditary cancer-associated missense mutations in hMSH6 uncouple ATP hydrolysis from DNA mismatch binding.

Authors:  Jennifer L Cyr; Christopher D Heinen
Journal:  J Biol Chem       Date:  2008-09-11       Impact factor: 5.157

8.  Tumor testing to identify lynch syndrome in two Australian colorectal cancer cohorts.

Authors:  Daniel D Buchanan; Mark Clendenning; Christophe Rosty; Dallas English; Mark A Jenkins; Stine V Eriksen; Michael D Walsh; Rhiannon J Walters; Stephen N Thibodeau; Jenna Stewart; Susan Preston; Aung Ko Win; Louisa Flander; Driss Ait Ouakrim; Finlay A Macrae; Alex Boussioutas; Ingrid M Winship; Graham G Giles; John L Hopper; Melissa C Southey
Journal:  J Gastroenterol Hepatol       Date:  2017-02       Impact factor: 4.029

9.  Evaluation of clinical criteria for the identification of Lynch syndrome among unselected patients with endometrial cancer.

Authors:  Amanda S Bruegl; Bojana Djordjevic; Brittany Batte; Molly Daniels; Bryan Fellman; Diana Urbauer; Rajyalakshmi Luthra; Charlotte Sun; Karen H Lu; Russell R Broaddus
Journal:  Cancer Prev Res (Phila)       Date:  2014-04-25

10.  Prevalence of defective DNA mismatch repair and MSH6 mutation in an unselected series of endometrial cancers.

Authors:  Paul J Goodfellow; Barbara M Buttin; Thomas J Herzog; Janet S Rader; Randall K Gibb; Elizabeth Swisher; Katherine Look; Ken C Walls; Ming-Yu Fan; David G Mutch
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.